| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |